Related Experiment Videos
The case for a biologically based classification of prostate cancer
1Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Center, Houston, TX 77030, USA.
Seminars in Oncology
|October 23, 2003
Summary
Integrated multidisciplinary cancer therapy, guided by clinical biology, is essential for adult cancer cure. Understanding malignancy and developing classifications based on biological features are key to advancing treatment strategies.
Area of Science:
- Oncology
- Cancer Biology
- Therapeutics
Background:
- Effective adult cancer treatment necessitates integrated multidisciplinary therapy.
- Therapeutic strategies rely on a deep understanding of malignancy and clinical biology.
- Successful interventions combine various modalities based on biological insights.
Purpose of the Study:
- To emphasize the central role of clinical biology in cancer therapy development.
- To highlight the importance of classification systems based on clinical and biological features.
- To underscore the axiomatic requirement for integrated multidisciplinary approaches in adult cancer cure.
Main Methods:
- Review of successful integrated multidisciplinary therapy examples in adult cancer.
- Analysis of the application of agents (chemotherapy, biologics) and modalities (radiation, surgery) based on clinical biology.
- Examination of the relationship between understanding clinical biology and therapy development.
Main Results:
- Integrated multidisciplinary therapy is axiomatic for adult cancer cure.
- Successful application of therapeutic agents and modalities is contingent on understanding clinical biology.
- Development of classifications based on clinical and biological features is central to therapy advancement.
Conclusions:
- A comprehensive understanding of malignancy and its clinical biology is fundamental for developing effective cancer therapies.
- Integrated multidisciplinary approaches, informed by biological insights and robust classification, are crucial for improving outcomes in adult cancer.
- Future therapy development must prioritize the integration of biological understanding and multidisciplinary treatment strategies.